US Stock MarketDetailed Quotes
KTTA Pasithea Therapeutics
- 6.9501
- -0.1399-1.97%
Trading Apr 24 12:30 ET
7.24MMarket Cap-18784P/E (TTM)
6.9501High6.9501Low881Volume6.9300Open7.0900Pre Close6.12KTurnover0.12%Turnover RatioLossP/E (Static)1.04MShares17.400052wk High0.31P/B5.20MFloat Cap5.254052wk Low--Dividend TTM748.76KShs Float170.0000Historical High--Div YieldTTM0.00%Amplitude5.2540Historical Low6.9500Avg Price1Lot Size
About Pasithea Therapeutics Company
Pasithea Therapeutics Corp. is a biotechnology company focuses on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Steinman Lawrence J in May, 2020 and is headquartered in Miami Beach, FL.
Company Profile
SymbolKTTA
Company NamePasithea Therapeutics
Listing DateSep 15, 2021
Issue Price4.99
Founded2020
CEODr. Tiago Reis Marques
MarketNASDAQ
Employees8
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1111 Lincoln Road,Suite 500
CityMiami Beach
ProvinceFlorida
CountryUnited States of America
Zip Code33139
Phone1-702-514-4174
Websitehttp://www.pasithea.com
Company Executives
- Name
- Position
- Salary
- Dr. Tiago Reis Marques
- Chief Executive Officer and Director
- 539.50K
- Dr. Graeme Martin Currie, PhD
- Chief Development Officer
- --
- Daniel Schneiderman
- Chief Financial Officer and Principal Accounting Officer
- 367.20K
- Dr. Lawrence J. Steinman, M.D.
- Executive Chairman of the Board
- 250.00K
- Alfred J Novak
- Independent Director
- 63.59K
- Simon Dumesnil
- Independent Director
- 60.00K
- Dr. Emer Leahy
- Independent Director
- 60.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg